Authors:
OBRIEN SM
HATFIELD ARW
CRAIG PI
WILLIAMS SP
Citation: Sm. Obrien et al., A 5-YEAR FOLLOW-UP OF SELF-EXPANDING METAL STENTS IN THE ENDOSCOPIC MANAGEMENT OF PATIENTS WITH BENIGN BILE-DUCT STRICTURES, European journal of gastroenterology & hepatology, 10(2), 1998, pp. 141-145
Authors:
KANTARJIAN HM
GILES FJ
OBRIEN SM
TALPAZ M
Citation: Hm. Kantarjian et al., CLINICAL COURSE AND THERAPY OF CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON-ALPHA AND CHEMOTHERAPY, Hematology/oncology clinics of North America, 12(1), 1998, pp. 31
Authors:
ROBBINS AH
BORDEN MD
WINDMILLER BS
NIEZGODA M
MARCUS LC
OBRIEN SM
KREINDEL SM
MCGUILL MW
DEMARIA A
RUPPRECHT CE
ROWELL S
Citation: Ah. Robbins et al., PREVENTION OF THE SPREAD OF RABIES TO WILDLIFE BY ORAL VACCINATION OFRACCOONS IN MASSACHUSETTS, Journal of the American Veterinary Medical Association, 213(10), 1998, pp. 1407-1412
Authors:
RATAIN MJ
SKOOG LA
OBRIEN SM
COOPER N
SCHILSKY RL
VOGELZANG NJ
GERBER M
NARANG PK
NICOL SJ
Citation: Mj. Ratain et al., PHASE-I STUDY OF 3'-DEAMINO-3'-(2-METHOXY-4-MORPHOLINYL)DOXORUBICIN (FCE-23762, PNU-152243) ADMINISTERED ON A DAILY X3 SCHEDULE, Annals of oncology, 8(8), 1997, pp. 807-809
Authors:
KANTARJIAN HM
OBRIEN SM
KEATING M
BERAN M
ESTEY E
GIRALT S
KORNBLAU S
RIOS MB
DEVOS D
TALPAZ M
Citation: Hm. Kantarjian et al., RESULTS OF DECITABINE THERAPY IN THE ACCELERATED AND BLASTIC PHASES OF CHRONIC MYELOGENOUS LEUKEMIA, Leukemia, 11(10), 1997, pp. 1617-1620
Authors:
FLEMING GF
OBRIEN SM
HOFFMAN PC
VOKES EE
VOGELZANG NJ
SCHILSKY RL
WAGGONER SE
RATAIN MJ
Citation: Gf. Fleming et al., PHASE-I STUDY OF TREATMENT WITH ORAL 13-CIS-RETINOIC ACID, SUBCUTANEOUS INTERFERON ALFA-2A, CISPLATIN, AND 24-HOUR INFUSION 5-FLUOROURACIL LEUCOVORIN/, Cancer chemotherapy and pharmacology, 39(3), 1997, pp. 227-232
Citation: Sm. Obrien et al., CHARACTERIZATION OF NONPOROUS MAGNETIC CHELATOR SUPPORTS AND THEIR USE TO RECOVER POLYHISTIDINE-TAILED T4 LYSOZYME FROM A CRUDE ESCHERICHIA-COLI EXTRACT, Journal of biotechnology, 54(1), 1997, pp. 53-67
Authors:
OBRIEN SM
CAMPBELL GR
BURKE AF
MAGUIRE OC
ROWLANDS BJ
FITZGERALD MX
HEGARTY JE
Citation: Sm. Obrien et al., SERUM BILE-ACIDS AND URSODEOXYCHOLIC ACID TREATMENT IN CYSTIC FIBROSIS-RELATED LIVER-DISEASE, European journal of gastroenterology & hepatology, 8(5), 1996, pp. 477-483
Authors:
LARSON RA
MICK R
SPIELBERGER RT
OBRIEN SM
RATAIN MJ
Citation: Ra. Larson et al., DOSE-ESCALATION TRIAL OF CLADRIBINE USING 5 DAILY INTRAVENOUS INFUSIONS IN PATIENTS WITH ADVANCED HEMATOLOGIC MALIGNANCIES, Journal of clinical oncology, 14(1), 1996, pp. 188-195
Citation: Sm. Obrien et al., NONPOROUS MAGNETIC CHELATOR SUPPORTS FOR PROTEIN RECOVERY BY IMMOBILIZED METAL AFFINITY ADSORPTION, Journal of biotechnology, 50(1), 1996, pp. 13-25
Authors:
SLOANE RP
WARD JM
OBRIEN SM
THOMAS ORT
DUNNILL P
Citation: Rp. Sloane et al., EXPRESSION AND PURIFICATION OF A RECOMBINANT METAL-BINDING T4 LYSOZYME FUSION PROTEIN, Journal of biotechnology, 49(1-3), 1996, pp. 231-238
Authors:
FERNANDEZ MC
WALTER FG
KLOSTER JC
OBRIEN SM
BRADY LA
VILLARIN A
RUFFENACH SJ
PROSNITZ EH
SALMON JV
Citation: Mc. Fernandez et al., HEMODIALYSIS AND HEMOPERFUSION FOR TREATMENT OF VALPROIC ACID AND GABAPENTIN POISONING, Veterinary and human toxicology, 38(6), 1996, pp. 438-443
Authors:
LILENBAUM RC
RATAIN MJ
MILLER AA
HARGIS JB
HOLLIS DR
ROSNER GL
OBRIEN SM
BREWSTER L
GREEN MR
SCHILSKY RL
Citation: Rc. Lilenbaum et al., PHASE-I STUDY OF PACLITAXEL AND TOPOTECAN IN PATIENTS WITH ADVANCED TUMORS - A CANCER AND LEUKEMIA GROUP-B STUDY, Journal of clinical oncology, 13(9), 1995, pp. 2230-2237
Authors:
PRETI HA
HUH YO
OBRIEN SM
ANDREEFF M
PIERCE ST
KEATING M
KANTARJIAN HM
Citation: Ha. Preti et al., MYELOID MARKERS IN ADULT ACUTE LYMPHOCYTIC-LEUKEMIA - CORRELATIONS WITH PATIENT AND DISEASE CHARACTERISTICS AND WITH PROGNOSIS, Cancer, 76(9), 1995, pp. 1564-1570
Authors:
CORTES JE
TALPAZ M
BERAN M
OBRIEN SM
RIOS MB
STASS S
KANTARJIAN HM
Citation: Je. Cortes et al., PHILADELPHIA CHROMOSOME-NEGATIVE CHRONIC MYELOGENOUS LEUKEMIA WITH REARRANGEMENT OF THE BREAKPOINT CLUSTER REGION - LONG-TERM FOLLOW-UP RESULTS, Cancer, 75(2), 1995, pp. 464-470
Authors:
CORTES J
OBRIEN SM
PIERCE S
KEATING MJ
FREIREICH EJ
KANTARJIAN HM
Citation: J. Cortes et al., THE VALUE OF HIGH-DOSE SYSTEMIC CHEMOTHERAPY AND INTRATHECAL THERAPY FOR CENTRAL-NERVOUS-SYSTEM PROPHYLAXIS IN DIFFERENT RISK GROUPS OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA, Blood, 86(6), 1995, pp. 2091-2097
Authors:
FLEMING GF
RATAIN MJ
OBRIEN SM
SCHILSKY RL
HOFFMAN PC
RICHARDS JM
VOGELZANG NJ
KASUNIC DA
EARHART RH
Citation: Gf. Fleming et al., PHASE-I STUDY OF ADOZELESIN ADMINISTERED BY 24-HOUR CONTINUOUS INTRAVENOUS-INFUSION, Journal of the National Cancer Institute, 86(5), 1994, pp. 368-372
Authors:
VOKES EE
OBRIEN SM
VOGELZANG NJ
SCHILSKY RL
RATAIN MJ
Citation: Ee. Vokes et al., 5-DAY INFUSIONAL FLUORODEOXYURIDINE WITH ORAL LEUCOVORIN AND ESCALATING DOSES OF INTERFERON-ALPHA-2B - A PHASE-I STUDY, Cancer chemotherapy and pharmacology, 32(5), 1993, pp. 347-352
Citation: Dj. Medyckyjscott et al., GENIE - A GLOBAL ENVIRONMENTAL NETWORK FOR INFORMATION EXCHANGE, Journal of information science, 19(5), 1993, pp. 403-406
Authors:
SAMUELS BL
MICK R
VOGELZANG NJ
WILLIAMS SF
SCHILSKY RL
SAFA AR
OBRIEN SM
RATAIN MJ
Citation: Bl. Samuels et al., MODULATION OF VINBLASTINE RESISTANCE WITH CYCLOSPORINE - A PHASE-I STUDY, Clinical pharmacology and therapeutics, 54(4), 1993, pp. 421-429